Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

171 results about "Mammary fluid" patented technology

Devices and methods for obtaining mammary fluid samples for evaluating breast diseases, including cancer

Biological samples of mammary fluid or components thereof are obtained using a breast pump device coupled with a solid phase sample collection medium, alternatively facilitated by administering oxytocin to the subject. The breast pump device stimulates expression of mammary fluid and provides for collection of diagnostic samples to evaluate breast disease, including cancer. The biological sample may include whole cells or cellular components, purified or bulk proteins, glycoproteins, peptides, nucleotides or other desired constituents comprising a breast disease marker. Methods, kits and adapter devices relating to the breast pump device are also provided. Yet additional methods, devices, accessories, and materials are provided for laboratory handling and processing of breast fluid samples and for related diagnostic methods.
Owner:ATOSSA THERAPEUTICS INC

Six percent-premix for lactating sows and wheat-type daily ration prepared from six percent-premix

The invention belongs to the field of feeds, and particularly relates to a six percent-premix for lactating sows and a wheat-type daily ration prepared from the six percent-premix. The premix comprises multivitamins, composite trace elements, DL-methionine, lysine, threonine, L-arginine, valine, composite electrolyte, compound enzyme, 5000 IU of phytase, functional additives, feed attractants, calcium hydrogen phosphate, stone powder, salt, choline, antioxidants and defatted rice bran. On the whole, the daily ration for the lactating sows is capable of protecting the development of mammary glands of the sows, ensuring plentiful milk with high quality in the lactation period of the sows and increasing the survival rate of suckling piglets, and enables the piglets to have higher weaning weight.
Owner:河南宏展生物科技有限公司

Breast pump for expressing milk from a breast

Breast pump for expressing milk from a breast, comprising at least one breast cup (2) for receiving a breast, a pumping system (10) in fluid connection (11) with the at least one breast cup (2) for applying a negative pressure on said breast and a detection unit (3) comprising at least one sensor for measuring a parameter during use of the breast pump (1), wherein the breast pump (1) is adapted for optimising breast pump settings by actively controlling at least one breast pump pumping property, based on measurements of the at least one sensor (4, 5), during a period of use of the breast pump (1), in order to personalise operation of said breast pump (1) for a particular user.
Owner:KONINKLIJKE PHILIPS ELECTRONICS NV

Method for the production of fusion proteins in transgenic mammal milk

Desirable fusion proteins can be produced in and purified from the milk of transgenic animals. The peptides are made as fusion proteins with a suitable fusion partner such as human alpha-fetoprotein. The fusion partner protein acts to promote and increase the half-life of the overall molecule as well as having therapeutic effects on its own. The fusion protein is typically produced through the use of transgenic animals and can be purified away from the now the milk or other bodily fluid of such an animal by an affinity purification method. A particular advantage of producing peptides via this route, in addition to the obvious advantages of high yield and biocompatibility, is that specific post-translational modifications, such as carboxy terminal amidation, can be performed in the mammary gland. Biologically active polypeptides comprising a therapeutically active polypeptide fused to human alpha-fetoprotein fragment or a variant thereof, methods for the preparation thereof, nucleotide sequences encoding such fusion polypeptides, expression cassettes comprising such nucleotide sequences, self-replicating plasmids containing such expression cassettes, and pharmaceutical compositions containing said fusion polypeptides.
Owner:GTC BIOTHERAPEUTICS INC

Human thrombopoietin expression vector and constructing method therefor

The invention belongs to the technical field of genetic engineering and transgenic engineering and in particular relates to a method for building mammary gland specific expression vectors of human thrombopoietin gene and goat beta-casein gene promoter. The vectors which are built are transferred to COS-7 and HC-11 cells and expressed on eukaryotic cell level verification hTPO. The built mammary gland specific expression vectors of the human thrombopoietin gene and the goat beta-casein gene promoter are applied to prepare a mammary gland bioreactor of transgenic animals and are expressed with high level in the milk of transgenic mammalian, and the vectors provide useful drug protein-hTPO for clinic. The mammary gland specific expression vectors of human thrombopoietin gene and goat beta-casein gene promoter which are provided by the invention provide a foundation for further research and development.
Owner:上海医学遗传研究所 +2

Exosome separation method and separation device thereof

The invention provides an exosome separation method and a separation device thereof. The exosome separation method comprises the steps: firstly filtering or centrifuging blood, urea, saliva, cerebrospinal fluid, milk, ascetic fluid or amniotic fluid to remove impurities larger than 1 micrometer; then utilizing an even pore diameter anodized aluminum oxide film with the pore diameter correspondingto the diameter size of the exosome to filter, collecting filtrate or exosome on the even pore diameter anodized aluminum oxide film to obtain required exosome. The exosome separation device comprisesa membrane filter with the even pore diameter anodized aluminum oxide film as a filter membrane. By means of the separation method and the separation device thereof disclosed by the invention, the exosome can be simply and efficiently separated, the different sizes of exosome can be cut out and classified, and the different sizes of exosome can be respectively and correspondingly analyzed, researched and applied.
Owner:SHENZHEN TOPMEMBRANES INC

Process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby

The invention relates to a method of producing a protein of interest, comprising making a non-human transgenic mammal that produces said protein in its milk, obtaining said milk from the non-human transgenic mammal and purifying said protein of interest from the milk. Transgenic bovine animals were generated, which are able to produce human growth hormone in mammary glands. The method involves cloning of a genetic construct encoding hGH gene and beta casein promoter conveniently in an expression vector. It also includes transfection procedures into fetal bovine somatic cells, generally fibroblasts, and the nuclear transfer into enucleated bovine oocytes, generating thus transgenic embryos. The method also includes other procedures to generate transgenic embryos for the further expansion of the transgenic herd, such as the subcloning of transgenic female bovines, the superovulation of transgenic cows and their insemination with semen from a non-transgenic or a transgenic male bovine, and the superovulation of non-transgenic cows and their insemination with semen from a transgenic male bovine. Afterwards, transgenic embryos give rise to transgenic cattle that produce human growth hormone in huge amounts in their milk, from which the hormone is completely purified and analysed to fulfill all the requirements for the manufacture of a pure biopharmaceutical product.
Owner:STERRENBELD BIOTECH NORTH AMERICA

Composition for eliminating stagnation and promoting lactation and preparation method thereof

The invention discloses a mistura with effects of resolving hard mass and promoting lactation and a preparation method thereof, belonging to the field of traditional Chinese medicine. The composition is used for treating postpartum hypogalactia and breast milk silting-up and prepared by the following raw materials according to parts by weight: 30 parts of membranous milkvetch root, 15 parts of Chinese angelica, 15 parts of largehead atractylodes rhizome, 10 parts of beautiful sweetgum fruit, 10 parts of Chinese thorowax root, 6 parts of bitter orange (stir-fried, broken), 6 parts of pangolin scales, 10 parts of cowherb seed, 10 parts of uniflower swisscentaury root, 6 parts of Szechuan lovage rhizome, 15 parts of pilose Asiabell root, 10 parts of akebia stem, 10 parts of liquoric root and 600 parts of front pig trotters, the front pig trotters are stewed, then soup is used for decoction, and the mistura is prepared by concentration, bottling and disinfection. The invention can also make the addition and the subtraction based on the basic formula according to the symptoms. The mistura has low price, simple operation, convenient administration and no toxic side effects. The mistura can be made by patients, the cure rate for a variety of lack of milk, rare breast milk and breast duct blockage is 98.2 percent and the total effective rate is 100 percent. Compared with the other drugs at present, the effect is extremely significant.
Owner:段春英 +1

Pump unit for a breast pump

The present invention relates to a pump unit for a breast pump for extracting milk from a human breast, comprising a motor for driving the pump unit, wherein the motor is configured to provide a motor feedback signal; a control unit for providing a control signal for controlling the motor; and an estimator for estimating a pressure provided by the pump unit based on the motor feedback signal and the control signal; wherein the control unit is configured to adjust the control signal based on the estimated pressure.
Owner:KONINKLJIJKE PHILIPS NV

Lactation-promoting and menstruation-inducing Chinese medicinal composition for puerperae

The invention provides a lactation-promoting and menstruation-inducing Chinese medicinal composition for puerperae, which can regulate the functions of promoting lactation, inducing menstruation, removing blood stasis, replenishing blood, nourishing qi and promoting body fluid of the puerperae comprehensively. According to the lactation-promoting and menstruation-inducing Chinese medicinal composition, anemone clematis stem, corn stigma, lettuce seed, dwarf lilyturf tuber and rose are used as a monarch medicine and have the effects of promoting blood circulation, regulating menstruation and promoting lactation; cassia bark, chestnut, medlar, cinnamomvine and loofah are used as a minister medicine and exert a secondary effect to solve the problem of galactostasis and realize the functions of dredging collaterals and inducing menstruation; carrot, pumpkin, glutinous rice, papaya and malt are used as an assistant medicine, have a coordinative effect in a formula or have a treatment effect of enhancing the monarch medicine and the minister medicine and inhibit the toxic and side effects of other medicines; and almond, Chinese date, prepared rehmannia root, turmeric and cowherb seed assists the medicines to exert the effects of promoting blood circulation, promoting lactation and blending the medicines. According to the formula, blood circulation-promoting and blood stasis-reducing medicines are supplemented on the basis of lactation promotion and menstruation induction, and the blood stasis-reducing medicines are combined with medicines for treating various accompanied symptoms, so that an effect of blending the medicines is achieved, and a reasonable formula of the Chinese medicinal composition for treating postpartum galactostasis, mammary swelling, acute mastitis, blood stasis pain, body deficiency and hypodynamia is formed.
Owner:河北永丰药业有限公司

Device, system and method of non-invasive diagnosis of mastitis in a dairy cow

A device, system, and method employ spectrometry to interrogate udder tissue or milk to diagnose clinical and sub-clinical mastitis.
Owner:GRABEK JAMES R +1

Cow feed and preparation method thereof

The invention discloses cow feed and a preparation method thereof. The feed comprises alfalfa hay, pumpkins, rice straw, corn stalks, wheat straw, soya bean meal, rice bran, green stalks, maize germ meal, cottonseed meal, wheat bran, wheat middlings, sunflower seeds, DDGS, whole cottonseeds, carrot, choline chloride, potassium iodide, beer brewer grains, citric acid, magnesium sulfate, tricalcium phosphate, sodium selenite, cod-liver oil, salt, vitamin premix and microelement premix. The preparation method includes a breaking step, a blending step and a pelletizing step. The cow feed and the preparation method thereof have the advantages that the feed has the effects of benefiting qi, nourishing blood and promoting lactation, qi and blood deficiency type cow postpartum hypogalactia can be treated, breast plumpness and normal nipple development can further be promoted, milk is full, and the immunity of cows is improved; moreover, normal grow of cow mammary glands and other body organs can be well guaranteed; the cure rate is high, the feed becomes effective quickly, the course of treatment is short and no toxic and side effects exist.
Owner:SHANDONG NEW HOPE LIUHE GROUP

Traditional Chinese medicine for tonifying qi and increasing breast milk

The invention relates to a traditional Chinese medicine which is suitable for parturient women with hypogalactia during lactation, a preparation method and a detection method thereof. According to the invention, Chinese angelica and Astragalus mongholicus are used as the principal drugs, Bupleurum Chinense and Ligusticum wallichii are used as the ministerial drugs, and Vaccaria segetalis, MedullaTetrapanacis and Fructus Liquidambaris are used as the adjuvant drugs. The traditional Chinese medicine provided by the invention has functions of tonifying qi and nourishing blood, relieving qi stagnancy in liver, and dredging collateral for promoting lactation, and can be used to treat symptoms such as postpartum hypogalactia or lactation deficiency; or clear and thin breast milk; or pale complexion, mental fatigue and deprivation; or hypochondriac and distending pains as well as depressed mood.
Owner:沈楠

Infant feed and method

InactiveUS20170172167A1Raise countReduces bacterial cell countMilk preparationFood scienceBreast feedNutrition
The present disclosure relates generally to a composition for feeding an infant. More particularly, the disclosure relates to a nutritional composition for feeding an infant comprising a stem-cell deficient first component and a second component comprising breast milk stem cells (BSCs). The second component is added to the first component, and the BSCs partially or fully replenish the stem-cell deficient first component with respect to BSCs. In some embodiments the first component is stem-cell deficient human breast milk and the second component comprises BSCs from the infant's mother's own milk. The compositions of the present disclosure have been developed primarily as a personalized, nutritional composition providing the beneficial effects of an infant's mother's own BSCs to the infant while not being able to receive the full benefits of being breastfed directly.The present disclosure also relates to a composition for feeding an infant and to processes of their production. In particular, the disclosure relates to a composition for feeding an infant comprising a first and a second component, wherein the first component provides the majority of the nutritional value to said composition, and wherein the second component comprises at least one live bacterium from human breast milk or the lactating human mammary gland. The disclosure has been developed primarily as a composition for feeding a mother's own infant, wherein the composition comprises processed human breast milk with a substantially reduced live bacterial cell count as compared to unprocessed breast milk but which at least one live bacterium, from the mother's own breast milk, is added such as to partially or fully replenish the processed human breast milk with respect to the at least one live bacterium. More particular, the composition is a personalised composition for feeding the mother's own preterm infant.The present invention also related to the combination of BSC and bacterial replenishment as described herein.
Owner:MEDELA HLDG AG

Oral administered agent with milk secretion promoting function

InactiveCN1654065AAdequate secretionPromote secretionUnknown materialsSexual disorderMilk Let-downSugar
The orally taken preparation for promoting lactation is prepared with five kinds of material including astragalus root, cowherb seed, red sage, ricepaper pith and brown sugar in certain proportion. The preparation process includes water decocting the first four kinds of medicine materials and filtering to obtain medicine liquid A; water decocting the filter residue and filtering to obtain medicine liquid B; mixing the medicine liquid A, the medicine liquid B and brown sugar; and further decoction to form ointment or roasting into granule. The orally taken preparation has the functions of invigorate spleen and stomach, invigorating kidney, regulating the functions of liver, nourishing blood and Qi and dredging the muscles and joints, so that it has high effect of promoting lactation.
Owner:谭重春

Hands free bra kit for removing milk from the human breast

The present invention provides hands free bra kit for removing milk from the human breast comprising an adjustable neck strap, a bottom strap, a top strap a pair of loops, a pair of tension balls and a reinforced area. The hands free bra kit is a fully portable and compact kit. The neck strap is provided around the neck, the top strap is provided around top of breast shed and the bottom strap is provided around the waist. The loop is configured for inserting horn of the breast and the tension ball holds an encircled material on the breast horn. The reinforced area can be a thicken portion or a grommet designed to take the weight of the bra kit. A method for placing hands free kit on breast and method for massaging breast to remove the milk completely is also disclosed.
Owner:WESTON RICHARD SCOTT

Medicine for preventing and curing agalactia, lactation lack and mastitis of livestock and preparation method thereof

The invention provides a traditional Chinese medicine composition for preventing and curing the postpartum agalactia, lactation lack and mastitis of livestock. The composition comprises the following components according to the parts by weight: 3-13 of angelica dahurica, 3-13 of raw radix astragali, 3-13 of angelica, 0.5-3 of pangolin and 10-30 of walnut kernel, preferably 4-8 of angelica dahurica, 4-8 of raw radix astragali, 4-8 of angelica, 0.5-2 of pangolin and 15-25 of walnut kernel. The traditional Chinese medicine composition has the functions of invigorating the vital energy, nourishing blood and Yin, promoting body fluid production, stimulating the menstrual flow, generating breast milk, resisting bacteria, diminishing inflammation, and the like, can be used for treating the postpartum agalactia or lactation lack and mastitis of livestock, such as cows, sheep, pigs, and the like, and has the obvious treatment effect and no medicine residues in the breast milk or toxic side effects. The invention also provides a preparation method of the traditional Chinese medicine composition.
Owner:BEIJING DABEINONG ANIMAL HEALTH TECH

Food for promoting lactation and preparation method of food

The invention provides a food for promoting lactation and a preparation method of the food. The food is prepared from the following raw materials in parts by weight: 500-750 parts of wild live crucian, 100-150 parts of peanuts, 100-150 parts of millet. 100-150 parts of phaseolus calcaratus, 100-150 parts of red beans, 80-100 parts of black beans, 20-30 parts of luffa, 20-30 parts of beef, 20-30 parts of black sesame, 10-15 parts of longan, 10-15 parts of cinnamon and 10-15 parts of Chinese dates. The food and the preparation method provided by the invention have the advantages that great retention, release and maximum absorption and utilization of nutrition of the raw materials for a human body are realized, the effect is rapid, the functions of tonifying qi and blood, strengthening spleen and stomach, relieving liver depression, regulating yin and yang, nourishing blood and yin, invigorating and promoting lactation can be achieved for a puerpera, and the food not only can help the postpartum breast milk secretion, but also is beneficial to generating essence, nourishing blood, and promoting lactation, can help regulation of postpartum insufficiency of qi and blood and inappetence, and can prevent the postpartum breast diseases and promote the restoration of a puerpera body.
Owner:林乐程

General-purpose highly effective eukaryon expression carrier p3I-GFPN and mastitis-resisting transgene carrier constructed by the same

The invention discloses a universal efficient eukaryotic expression vector p3I-GFPN and an anti-mastitis transgenic vector which is constructed by employing the vector. The anti-mastitis transgenic vector pCMV / CSN2-hLY-hIFA constructed by the invention can express green fluorescent protein at a high level in mammary gland cell. In the mammary gland cell of lactation period, initiation effect exerted by promoter of CSN2 enables the mammary gland cell of transformed pCMV / CSN2-hLY-hIFA to secrete a plurality of human lysozyme and human interferon A, and achieve target protein via breast milk separation and preferably fight against mastitis of livestock simultaneously.
Owner:NORTHWEST A & F UNIV

Process for producing exogenous protein in the milk of transgenic mammals and a process for purifying proteins therefrom

The invention relates to a method of producing a protein of interest, comprising making a non-human transgenic mammal that produces said protein in its milk, obtaining said milk from the non-human transgenic mammal and purifying said protein of interest from the milk. Transgenic bovine animals were generated, which are able to produce human growth hormone in mammary glands. The method involves cloning of a genetic construct encoding hGH gene and beta casein promoter conveniently in an expression vector. It also includes transfection procedures into fetal bovine somatic cells, generally fibroblasts, and the nuclear transfer into enucleated bovine oocytes, generating thus transgenic embryos. The method also includes other procedures to generate transgenic embryos for the further expansion of the transgenic herd, such as the subcloning of transgenic female bovines, the superovulation of transgenic cows and their insemination with semen from a non-transgenic or a transgenic male bovine, and the superovulation of non-transgenic cows and their insemination with semen from a transgenic male bovine. Afterwards, transgenic embryos give rise to transgenic cattle that produce human growth hormone in huge amounts in their milk, from which the hormone is completely purified and analysed to fulfill all the requirements for the manufacture of a pure biopharmaceutical product.
Owner:STERRENBELD BIOTECH NORTH AMERICA

Medicinal composition for treating hypogalactia symptom of dairy cow and preparation method thereof

The invention discloses a medicinal composition for treating hypogalactia symptom of a dairy cow and a preparation method thereof. The medicinal composition comprises the following raw materials of lythrum, radix aucklandiae, girald jasmine root, the root of three-nerved spicebush, rhizoma nardostachyos, Omei meadowrue herb, aspongopus, urtica dioica, pericarpium citri reticulatae viride, jujube, radix bupleuri, paederia scandens, nutgrass galingale rhizome, kohlrabi, lucid ganoderma, Chinese buckeye seed, calyx of singharanut, aiomatic turmeric root-tuber, woody hawksbeard root, rose, Japanese cayratia herb, semen raphani, rhizome of large-headed atractylodes, Australian cowplant root or leaf, hawthorn, hindu datura seed fruit, malt, rice-grain sprout, japanese balanophora, dangshen, turnip, Chinese yam and ficus pumila fruit. The medicinal composition disclosed by the invention has the benefits that the medicinal composition is mainly used for nourishing spleen and regulating qi and is assisted for reinforcing qi and enriching blood; the immunity of the dairy cow is improved, the lactation yield, the milk-fat percentage, the milk protein content, the lactose content and the content of dry substances in the milk can be improved; the breast plump and normal development of a nipple are promoted; milk is full, and the phenomenon of sudden decrease of appetite or inability to eat is avoided; the medicinal composition has the advantages of few toxic or side effects and remarkable effect; in addition, normal growth of mammary gland and other organs of the dairy cow can be better guaranteed.
Owner:SHANDONG NEW HOPE LIUHE GROUP

Process for producing exogenous protein in the milk of transgenic mammals and a process for purifying proteins therefrom

The invention relates to a method of producing a protein of interest, comprising making a non-human transgenic mammal that produces said protein in its milk, obtaining said milk from the non-human transgenic mammal and purifying said protein of interest from the milk. Transgenic bovine animals were generated, which are able to produce human growth hormone in mammary glands. The method involves cloning of a genetic construct encoding hGH gene and beta casein promoter conveniently in an expression vector. It also includes transfection procedures into fetal bovine somatic cells, generally fibroblasts, and the nuclear transfer into enucleated bovine oocytes, generating thus transgenic embryos. The method also includes other procedures to generate transgenic embryos for the further expansion of the transgenic herd, such as the subcloning of transgenic female bovines, the superovulation of transgenic cows and their insemination with semen from a non-transgenic or a transgenic male bovine, and the superovulation of non-transgenic cows and their insemination with semen from a transgenic male bovine. Afterwards, transgenic embryos give rise to transgenic cattle that produce human growth hormone in huge amounts in their milk, from which the hormone is completely purified and analysed to fulfill all the requirements for the manufacture of a pure biopharmaceutical product.
Owner:STERRENBELD BIOTECH NORTH AMERICA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products